Lichen Sclerosus
20
2
2
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
2 terminated out of 20 trials
81.8%
-4.7% vs benchmark
10%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (20)
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life
Laser vs Clobetasol for Lichen Sclerosus
Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen Sclerosus
Vaginal Ecosystem and Network in the United States Study
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus
Genital Lichen Sclerosus - Epidemiology, Comorbidities and the Role of Vulvar and Penile Microbiome
a Flexible Wound Dressing for the Management of Genital Skin Conditions
MonaLisa Touch Laser for the Treatment of Vulvar Lichen Sclerosus
Vulvar Mucosal Specialty Clinic Chart Review
Vulvar Scarring Grading Scale for Lichen Sclerosus
Lichen Sclerosus - the Influence on Quality of Life
Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar Dermatosis
Safety and Efficacy of Laser Therapy in Gynaecology
Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus
Biomarkers of Lichen Sclerosus
Nd:Yttrium Aluminum Garnet Laser Treatment for Lichen Sclerosus
Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease
Platelet Rich Plasma Injections for Vulvar Lichen Sclerosus
Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus